These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1601 related articles for article (PubMed ID: 33472669)

  • 1. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer.
    Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y
    ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
    Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
    Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer.
    Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y
    J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of NO Donor-Aurovertin Hybrids as Dual Ferroptosis and Apoptosis Inducers for Treating Triple Negative Breast Cancer.
    Ma LF; Xu LL; Yuan LJ; Yang X; Wu R; Bao SM; Chen YL; Duan HL; Fang L; Zhao HJ; Zhan ZJ
    J Med Chem; 2024 Aug; 67(15):13089-13105. PubMed ID: 39044437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
    Li H; Liu W; Zhang X; Wu F; Sun D; Wang Z
    Biochem Biophys Res Commun; 2021 Dec; 585():111-116. PubMed ID: 34800882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer.
    Chen YM; Xu W; Liu Y; Zhang JH; Yang YY; Wang ZW; Sun DJ; Li H; Liu B; Chen LX
    Int J Biol Sci; 2023; 19(8):2531-2550. PubMed ID: 37215985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Withanolides from
    Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
    Mokhtarpour K; Razi S; Rezaei N
    Breast Cancer Res Treat; 2024 Oct; 207(3):497-513. PubMed ID: 38874688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4.
    Zhang W; Jiang B; Liu Y; Xu L; Wan M
    Free Radic Biol Med; 2022 Feb; 180():75-84. PubMed ID: 35038550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε.
    Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A
    FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
    Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
    Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
    Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
    Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer.
    Hou Y; Cai S; Yu S; Lin H
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):333-341. PubMed ID: 33522578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
    Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in small-molecule drug discovery for triple-negative breast cancer.
    Fosu-Mensah N; Peris MS; Weeks HP; Cai J; Westwell AD
    Future Med Chem; 2015; 7(15):2019-39. PubMed ID: 26495746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer.
    Long L; Xu J; Qi X; Pen Y; Wang C; Jiang W; Peng X; Hu Z; Yi W; Xie L; Lei X; Wang Z; Zhuo L
    Eur J Med Chem; 2024 Jul; 273():116500. PubMed ID: 38776807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer.
    Wei Y; Zhu Z; Hu H; Guan J; Yang B; Zhao H
    Eur J Pharmacol; 2022 Jun; 924():174970. PubMed ID: 35469839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells.
    Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R
    Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.